BiotechTube
Home/eFFECTOR Therapeutics/Alfred L. Garfall
AL

Alfred L. Garfall

Board Member

eFFECTOR Therapeutics

Therapeutic Areas

Oncology

eFFECTOR Therapeutics Pipeline

DrugIndicationPhase
ZotatifinKRAS-mutant NSCLC; ER+ Breast CancerPhase 1b/2
TomivosertibMetastatic Castration-Resistant Prostate Cancer (mCRPC)Phase 2

Leadership Team at eFFECTOR Therapeutics

SW
Steve Worland
Former President & CEO
MB
Michael Byrnes
Former CFO
DW
Douglas Warner
Former CMO
View full eFFECTOR Therapeutics profile